NCT01490489View on ClinicalTrials.gov

EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction

NACompletedINTERVENTIONAL

Enrollment

142

Participants

Timeline

Start Date

July 11, 2011

Primary Completion Date

March 31, 2015

Study Completion Date

March 13, 2015

Conditions

Pre-eclampsiaIntra-uterine Growth Retardation

Interventions

OTHER

blood sample and doppler Ultrasound of uterine arteries

"* 36 ml of blood samples (serum and plasma) will be collected~* After a bed rest supine for 15 minutes, ultrasound Doppler from each of the uterine arteries will be performed to search for Notch"

Trial Locations (1)

38043

Clinical investigation center of the Grenoble University Hospital, Grenoble

All Listed Sponsors

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT01490489 - EG-VEGF : Potential Marker of Pre-eclampsia and / or Intrauterine Growth Restriction | Biotech Hunter | Biotech Hunter